Erwan Muros-Le Rouzic

4PUBLICATIONS
7CO-AUTHORS
Predictive and prognostic markersMajor global burdens of diseaseSocio-economic developmentMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 18, 2024
Five-year efficacy outcomes of ocrelizumab in relapsing multiple sclerosis: A propensity-matched comparison of the OPERA studies with other disease-modifying therapies in real-world lines of treatments.

Erwan Muros-Le Rouzic, Yanic Heer, Sean Yiu

|Jul 01, 2024
Cost and Quality of Life of Disability Progression in Multiple Sclerosis Beyond EDSS: Impact of Cognition, Fatigue, and Limb Impairment.

Jürgen Wasem, Yanic Heer, Eleni Karamasioti

|Aug 02, 2023
The socioeconomic impact of disability progression in multiple sclerosis: A retrospective cohort study of the German NeuroTransData (NTD) registry.

Paul Dillon, Yanic Heer, Eleni Karamasioti

|Jun 20, 2022
Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patients.

Gisella Guerrera, Alessandra Mandelli, Annamaria Finardi

Pageof 1

Frequent Collaborators

2 joint publications

Stefan Braune

1 joint publications

Alessandra Mandelli

1 joint publications

Damiano Marastoni

1 joint publications

Marco Salvetti